44
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Comparison of the Gastrointestinal Side Effects of Naproxen Formulated as Plain Tablets, Enteric-Coated Tablets, Or Enteric-Coated Granules in Capsules

, , , , &
Pages 65-73 | Published online: 08 Jul 2009

References

  • Somerville K W, Hawkey C J. Non-steroidal antiinflammatory agents and the gastrointestinal tract. Postgrad Med J 1986; 62: 23–28
  • Lanza F L. Endoscopic studies of gastric and duodenal injury after the use of Ibuprofen, asprin, and other non-steroid anti-inflammatory agents. Am J Med 1984; 77: 19–24
  • Caruso I, Porro G B. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980; 280: 75
  • Bjarnason I, Peters T J. In vitro determination of small intestinal permeability. Demonstration of a ‘persistent defect in patients with coeliac disease. Gut 1984; 25: 145–150
  • Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel M J, Levi A J. Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–489
  • Bjarnason I, Prouse P, Smith T, Gumpel M J, Zanelli G, Smethurst P, Levi S, Levi A J. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. ' Lancet 1987; 2: 711–714
  • Langman M JS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347–349
  • Lanza F L, Royer G L, Nelson R S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303(3)136–138
  • Hoftiezer J W, Silvoso G R, Burks M, Ivey K J. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; 2: 609–612
  • Trondstad R I, Aadland E, Holler T, Olaussen B. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects. Scand J Gastroenterol 1985; 20: 239–242
  • Osnes M, Larsen L, Eidsaunet W, Thorn E. Effect of diclofenac and naproxen on gastroduodenal mucosa. Clin Pharmacol Ther 1979; 26(3)399–405
  • Bjarnason I, Prouse P, Smith T, Gumpel M J, Zanelli G, Smethurst P, Levi S, Levi A J. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987; 2: 711–714
  • Giercksky K-E, Revhaug A, Warloe T, Johnson J A. Medikamentelt indusert gastrointestinal bøtdning (kan hyppigheten reduseres?). Tidsskr Nor Laege-foren 1986; 106: 662–666
  • Rampton D S. Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol 1987; 22: 1–4
  • Davis S S, Hardy J G, Fara J W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986; 27: 886–892
  • Bjarnason I, Peters T J. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983; 323–325
  • Lehmann E L, Abrerd H JM. Nonparametrics: statistical method based on ranks. Hoiden-Day Inc, San Francisco 1975
  • Kendall M. Rank correlation methods. Charles Griffin & Co Ltd, London 1975
  • Montgomery D C. Design and analysis of experiments. John Wiley & Sons, New York 1984
  • Caldwell J. Therapeutic approaches to and management of NSAID-induced gastritis. Pract Gastroenterol 1986; 10(3)64–86
  • Stern A L, Ward F, Harley G. Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa. Am J Med 1987; 83(3B)83–85
  • Caldwell J R, Roth S H, Wu W C, Semble E L, Castell D O, Heller M D, Marsh W H. Sucralfate treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms and damage. Am J Med 1987; 83(3B)74–82
  • Rachmilewitz D. The role of H2-receptor antagonists in the prevention of NSAID-induced gastrointestinal damage. Aliment Pharmacol Ther 1988; 2S: 65–73
  • Berkowitz J M, Adler S N, Sharp J T, et al. Ran-iditine protects against gastroduodenal lesions associated with chronic aspirin therapy. Gastroenterology 1986; 90: 1345
  • Davies J, Collins A J, Dixon St J. The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs. Br J Rheumatol 1986; 25: 54–58
  • Roth S H, Bennett R E, Mitchell C S. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Arch Intern Med 1987; 147: 1798–1801
  • Ehsanullah R SB, Page M C, Tildesley G, et al. NSAID-induced gastroduodenal damage: effect of ranitidine prophylaxis. Gastroenterology 1988; 94: A111
  • Lanza F, Robinson M, Bowers J. A multi-center double-blind comparison of ranitidine vs placebo in the prophylaxis of nonsteroidal anti-inflammatory drug (NSAID) induced lesions in gastric and duodenal mucosae. Gastroenterology 1988; 94: A250
  • Hawkey C J, Walt R P. Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet 1986; 2: 1084–1086
  • Cohen M M, McCready D R, Clark L, Sevelius H. Protection against aspirin-induced antral and duodenal damage with enprostil. Gastroenterology 1985; 88: 382–386
  • Konturek S J, Kwiecien N, Obtulowicz W, Polanski M, Kopp B, Oleksy J. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1983; 24: 89–93
  • Lanza F, Aspinall R L, Swabb E A, et al. Double blind placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988; 95: 289
  • Lanza F, Peace K, Gustitus L, et al. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988; 83: 143–146
  • Bjarnason I, Smethurst P, Fenn G C, et al. Misoprostol reduces indomethacin-induced changes in human small intestine. Gastroenterol Int 1988; 1(suppl 1)A884
  • Grossman M I, Matsumoto K K, Lichter R J. Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 1961; 40: 383–388
  • Hoftiezer J W, Silvoso G R, Burks M, et al. Comparisons of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980; 2: 609–612
  • Lanca F L, Royer G L, Nelson R S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136–138
  • Trondstad R I, Aadland E, Holler T, Olaussen B. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects. Scand J Gastroenterol 1985; 20: 239–422
  • Trondstad R, Bell H, Holler T. Endoscopic evaluation of the effect of naproxen tablets and suppositories on the gastric mucosa in healthy volunteers [Abstract]. Endoscopy 1988; 20(suppl)58
  • Lanza F, Umbenhauer E R, Nelson R S, Rack M F, Daurio C P, White L A. A double-blind randomized placebo controlled gastroscopic study to compare the effects of Indomethacin capsules and suppositories on the gastric mucosa of healthy volunteers. J Rheumatol 1982; 9: 415–419
  • Bjarnason I, Williams P, Smethurst P, Peters T J, Levi A J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292–1297

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.